Showing 41–50 of 18298 results
3 June 2025
In a landmark gathering aimed at redefining the future of global health, over 50 experts, practitioners, and advocates convened at the...
3 June 2025
Published by: Institute of Development Studies
In September 2023, an outbreak of mpox caused by the monkeypox virus (MPXV) clade Ib was reported in Kamituga, a mining region in the...
2 June 2025
29 May 2025
Published by: Institute of Development Studies
The World Health Organization declared the second mpox public health emergency of international concern (PHEIC) in August 2024. Cases of...
28 May 2025
The International Centre for Tax and Development (ICTD), based at the Institute of Development Studies, is launching a Community of...
28 May 2025
Published by: Institute of Development Studies
This brief provides an overview of the experimental stages of vaccine development during a disease outbreak and highlights key...
27 May 2025
23 May 2025
Published by: Institute of Development Studies
The global debate on balancing incentives for innovation in the pharmaceutical industry and facilitating competition for greater access to affordable medicines and vaccines has intensified in the aftermath of the Covid-19 pandemic. Drug discovery and vaccine development are expensive processes involving significant research and development (R&D) costs.
